Shares of Virax Biolabs Group Limited (VRAX) are experiencing a significant surge on Monday, driven by the recent declaration of a global health emergency by the World Health Organization (WHO) regarding the mpox virus. As investors seek exposure to companies potentially involved in treating the virus, Virax Biolabs, with its focus on diagnostics and development of a T-Cell Test, has become a focal point.
Virax Biolabs specializes in distributing diagnostic test kits for various viral threats. The company is actively developing a proprietary T-Cell Test technology with the intention of creating an immunology profiling platform. This platform aims to assess an individual’s immune risk profile against major global viral threats, including mpox. The WHO’s declaration last Wednesday, citing a new clade of mpox and its rapid spread, has heightened concerns and prompted a global response.
Investors are closely monitoring the mpox outbreak and companies developing potential treatments, including GeoVax Labs, Inc. (GOVX). Virax Biolabs’ stock experienced temporary trading halts due to volatility on Monday before resuming regular trading.
How to Invest in VRAX Stock
If you’re interested in participating in the Virax Biolabs market, whether it’s buying shares or exploring alternative investment strategies, here’s a breakdown:
*
Buying Shares:
The most common way to invest in a company is through a brokerage account. You can find a list of potential trading platforms online. Many platforms allow you to purchase ‘fractional shares,’ enabling you to own portions of a stock without buying an entire share. This is particularly useful for stocks like Berkshire Hathaway, which can have a high share price.*
Shorting:
If you believe the share price of a company will decline, you can attempt to profit from this by shorting the stock. This process involves borrowing shares from a broker and selling them in the market. You hope to buy back the shares at a lower price later and pocket the difference. However, shorting is a complex process requiring access to an options trading platform or a broker who allows short selling.*
Options Trading:
Another way to profit from a potential share price decline is through options trading. You can buy a put option or sell a call option at a strike price above the current share price. Both strategies can generate profits if the share price falls.VRAX Price Action
As of Monday’s publication, Virax Biolabs shares have climbed a remarkable 204.9%, reaching $6.49. This surge underscores the significant market interest in companies perceived to have a role in addressing the mpox crisis.
